BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12213859)

  • 21. Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.
    Meixner M; Hellmich M; Dietlein M; Kobe C; Schicha H; Schmidt M
    Nuklearmedizin; 2013; 52(3):71-80. PubMed ID: 23483137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy.
    Beierwaltes WH; Nishiyama RH; Thompson NW; Copp JE; Kubo A
    J Nucl Med; 1982 Jul; 23(7):561-8. PubMed ID: 7086528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
    Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
    Kazaure HS; Roman SA; Sosa JA
    Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
    Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
    Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart.
    Haigh PI; Urbach DR
    Surgery; 2005 Dec; 138(6):1152-7; discussion 1157-8. PubMed ID: 16360403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deaths due to differentiated thyroid cancer: a South Island, New Zealand experience: 1984-2009.
    Brownlie BJ; Turner J; Abdelaal AS
    N Z Med J; 2012 Oct; 125(1363):13-21. PubMed ID: 23159897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in patients with differentiated thyroid carcinoma.
    Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
    Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of surgical treatment of papillary thyroid carcinoma].
    Zhang ZM; Li ZJ; Tang PZ; Xu ZG; An CM
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):779-82. PubMed ID: 22335912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary thyroid carcinoma and thyrotoxicosis.
    Plengvidhya N; Rathanavijitrasilp A; Sangruchi T; Nitiyanant W; Vannasaeng S; Piraphatdist T; Vichayanrat A
    Int J Clin Pract; 1997 Oct; 51(7):471-3. PubMed ID: 9536590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
    Lundgren CI; Hall P; Dickman PW; Zedenius J
    Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical treatment of papillary thyroid carcinoma: uni- and multivariate analysis of prognostic factors (TNM staging system included).
    Pelizzo MR; Toniato A; Grigoletto R
    J Exp Clin Cancer Res; 1997 Sep; 16(3):261-5. PubMed ID: 9387899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.
    Hales IB; McElduff A; Crummer P; Clifton-Bligh P; Delbridge L; Hoschl R; Poole A; Reeve TS; Wilmshurst E; Wiseman J
    J Clin Endocrinol Metab; 1992 Sep; 75(3):886-9. PubMed ID: 1517381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular variant of papillary thyroid carcinoma: a long-term follow-up.
    Passler C; Prager G; Scheuba C; Niederle BE; Kaserer K; Zettinig G; Niederle B
    Arch Surg; 2003 Dec; 138(12):1362-6. PubMed ID: 14662540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases.
    Rao RS; Parikh HK; Deshmane VH; Parikh DM; Shrikhande SS; Havaldar R
    Head Neck; 1996; 18(2):118-24; discussion 124-6. PubMed ID: 8647676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
    Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.